DCGI allows Biophore India to manufacture coronavirus drug Favipiravir API
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetails
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetailsNew Delhi: Biocon said Wednesday that its medical device to treat COVID-19 patient has received approval from the Drugs Controller ...
Read moreDetails
I t is the sign of the times, transcending geographical frontiers, that democracy is being grotesquely distorted, giving a...
Read moreDetails
In a landmark verdict, the Brazilian Supreme Federal Court, that country’s highest judicial authority, on 11 September convicted former president...
Read moreDetails
An American scholar has written a book in which he tries to explain China’s recent rise. Dan Wang’s thesis is...
Read moreDetails
India’s top anti-corruption watchdog, the CVC, has just delivered a stinging reality check to the CBI, and it’s not a...
Read moreDetails